en POLSKI
eISSN: 2084-9834
ISSN: 0034-6233
Reumatologia/Rheumatology
Current issue Archive Manuscripts accepted About the journal Supplements Editorial board Reviewers Abstracting and indexing Subscription Contact Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank


6/2005
vol. 43
 
Share:
Share:
abstract:

ARTYKUŁ PRZEGLĄDOWY/REVIEW PAPER
Cardiovascular system involvement in systemic lupus erythematosus – review and own observations. Serological risk factor of cardiological complications

Lidia Ostanek
,
Edyta Płońska
,
Marek Brzosko
,
Krzysztof Mokrzycki
,
Małgorzata Peregud-Pogorzelska
,
Katarzyna Fischer

Ru 2005; 43, 6: 373-378
Online publish date: 2005/12/22
View full text Get citation
 
Systemic lupus erythematosus is an autoimmune disease, in the course of which involvement of the circulatory system is one of the common systemic manifestations, very important from the prognostic point of view. Involvement the heart affects most commonly pericardium and valvular system; myocardium is affected rarely. Patients with SLE have a high risk of early atherosclerosis in the form of coronary disease and myocardial infarct. Unlike in the general population, risk factors of cardiovascular complications in the SLE patients are mainly antiphospholipid antibodies, duration of the disease, duration of glucocorticoid therapy, as well as lipid disorders, anti-oxLDL antibodies, and high levels of CRP, a1-antitripsin and homocystein. Own observations on cardiac manifestation in the SLE patients and serological risk factors related to cardiac involvement are discussed in the paper.
keywords:

systemic lupus erythematosus; heart abnormalities, serological risk factor, antiphospholipid antibodies




Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.